Leticia Varella

2.1k total citations · 1 hit paper
20 papers, 1.3k citations indexed

About

Leticia Varella is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Leticia Varella has authored 20 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in Leticia Varella's work include Advanced Breast Cancer Therapies (6 papers), Breast Cancer Treatment Studies (5 papers) and Multiple and Secondary Primary Cancers (4 papers). Leticia Varella is often cited by papers focused on Advanced Breast Cancer Therapies (6 papers), Breast Cancer Treatment Studies (5 papers) and Multiple and Secondary Primary Cancers (4 papers). Leticia Varella collaborates with scholars based in United States, Italy and United Kingdom. Leticia Varella's co-authors include W. Fraser Symmans, Giuseppe Viale, Patrick L. Fitzgibbons, Lisa M. McShane, Antonio C. Wolff, Lisa A. Carey, Daniel F. Hayes, Charles M. Perou, Emina Torlakovic and Jane Perlmutter and has published in prestigious journals such as Journal of Clinical Oncology, Nature reviews. Cancer and Blood.

In The Last Decade

Leticia Varella

17 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

2020 851 citations Kimberly H. Allison, M. Elizabeth H. Hammond et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leticia Varella United States	9	798	754	446	259	212	20	1.3k
Shannon McKernin United States	7	931 1.2×	817 1.1×	348 0.8×	211 0.8×	236 1.1×	7	1.4k
Tracey Weisberg United States	7	761 1.0×	818 1.1×	289 0.6×	203 0.8×	287 1.4×	14	1.3k
MM Regan Switzerland	9	1.0k 1.3×	1.1k 1.5×	294 0.7×	329 1.3×	377 1.8×	32	1.7k
P. Kelly Marcom United States	20	1.1k 1.4×	669 0.9×	304 0.7×	378 1.5×	108 0.5×	49	1.8k
Tammy Piper United Kingdom	11	470 0.6×	595 0.8×	213 0.5×	238 0.9×	168 0.8×	27	911
Yasuto Naoi Japan	23	662 0.8×	850 1.1×	290 0.7×	661 2.6×	276 1.3×	88	1.5k
David Huntsman Canada	17	681 0.9×	377 0.5×	295 0.7×	567 2.2×	177 0.8×	28	1.4k
K. David Voduc Canada	7	692 0.9×	794 1.1×	173 0.4×	287 1.1×	309 1.5×	8	1.2k
Eva Carrasco Spain	22	1.5k 1.8×	1.1k 1.5×	476 1.1×	358 1.4×	220 1.0×	77	2.0k
Elizabeth A. Mallon United Kingdom	14	822 1.0×	837 1.1×	220 0.5×	439 1.7×	196 0.9×	25	1.4k

Countries citing papers authored by Leticia Varella

Since Specialization

Citations

This map shows the geographic impact of Leticia Varella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leticia Varella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leticia Varella more than expected).

Fields of papers citing papers by Leticia Varella

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leticia Varella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leticia Varella. The network helps show where Leticia Varella may publish in the future.

Co-authorship network of co-authors of Leticia Varella

This figure shows the co-authorship network connecting the top 25 collaborators of Leticia Varella. A scholar is included among the top collaborators of Leticia Varella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leticia Varella. Leticia Varella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kirkner, Gregory J., Melissa E. Hughes, Leticia Varella, et al.. (2025). The association between young age at metastatic breast cancer diagnosis and overall survival in the EMBRACE study. npj Breast Cancer. 11(1). 96–96.

Post, Kathryn, Leticia Varella, Nora Horick, et al.. (2025). Development and refinement of a nurse-led, culturally sensitive intervention for adjuvant endocrine therapy initiation among patients with breast cancer. European Journal of Oncology Nursing. 79. 103010–103010.

Mayer, Erica L., Dario Trapani, Se Eun Kim, et al.. (2025). The TRADE study: A phase 2 trial to assess the tolerability of abemaciclib dose escalation in early-stage HR+/HER2- breast cancer.. Journal of Clinical Oncology. 43(16_suppl). 517–517.

Varella, Leticia & Massimo Cristofanilli. (2023). Evaluating Elacestrant in the Management of ER-Positive, HER2-Negative Advanced Breast Cancer: Evidence to Date. OncoTargets and Therapy. Volume 16. 189–196. 14 indexed citations

Vidula, Neelima, Senthil Damodaran, Nora Horick, et al.. (2023). Abstract OT1-11-01: Phase II study of talazoparib, a PARP inhibitor, in somatic BRCA1/2 mutant metastatic breast cancer identified by cell-free DNA or tumor tissue genotyping. Cancer Research. 83(5_Supplement). OT1–11. 1 indexed citations

Varella, Leticia & Ann H. Partridge. (2023). Approaching cancer during pregnancy. Nature reviews. Cancer. 24(3). 159–160. 1 indexed citations

Chen, Yalei, Leticia Varella, Tessa Cigler, et al.. (2022). Benefit of adjuvant chemotherapy in node-negative T1a versus T1b and T1c triple-negative breast cancer. Breast Cancer Research and Treatment. 192(1). 163–173. 10 indexed citations

Varella, Leticia & Shoshana M. Rosenberg. (2022). Breast Cancer Disparities Related to Young Age at Diagnosis. Current Breast Cancer Reports. 14(4). 174–179. 1 indexed citations

Allison, Kimberly H., M. Elizabeth H. Hammond, Mitch Dowsett, et al.. (2020). Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update. Archives of Pathology & Laboratory Medicine. 144(5). 545–563. 215 indexed citations

10.

Varella, Leticia, Megan Kruse, Xuefei Jia, et al.. (2020). Real-world Outcomes of Cyclin-dependent Kinase Inhibitors Continued Beyond First Disease Progression in Hormone Receptor-positive Metastatic Breast Cancer. Clinical Breast Cancer. 21(3). 205–209. 18 indexed citations

11.

Allison, Kimberly H., M. Elizabeth H. Hammond, Mitch Dowsett, et al.. (2020). Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update. Journal of Clinical Oncology. 38(12). 1346–1366. 851 indexed citations breakdown →

12.

Varella, Leticia, Xuefei Jia, Megan Kruse, et al.. (2019). Real-world clinical outcomes and toxicity in metastatic breast cancer patients treated with palbociclib and endocrine therapy. Breast Cancer Research and Treatment. 176(2). 429–434. 54 indexed citations

13.

Varella, Leticia, Megan Kruse, Xuefei Jia, et al.. (2019). Real-world evidence evaluating continuation of CDK4/6 inhibitors beyond first progression in hormone receptor-positive (HR+) metastatic breast cancer.. Journal of Clinical Oncology. 37(15_suppl). e12538–e12538. 9 indexed citations

14.

Varella, Leticia, Megan Kruse, Xuefei Jia, et al.. (2018). Real world clinical outcomes of palbociclib in hormone receptor positive (HR+) metastatic breast cancer (MBC) patients.. Journal of Clinical Oncology. 36(15_suppl). e13034–e13034. 3 indexed citations

15.

Varella, Leticia, Jame Abraham, & Megan Kruse. (2017). Revisiting the Role of Bevacizumab in the Treatment of Breast Cancer. Seminars in Oncology. 44(4). 273–285. 17 indexed citations

16.

Dutcher, Janice P., et al.. (2016). Occurrence of renal cell carcinoma and hematologic malignancies (predominantly lymphoid) in individuals and in families. Familial Cancer. 15(4). 677–687. 4 indexed citations

17.

Varella, Leticia, et al.. (2013). Association of renal cell carcinoma and hematologic malignancy.. Journal of Clinical Oncology. 31(6_suppl). 449–449. 2 indexed citations

18.

Varella, Leticia, et al.. (2012). Association of Renal Cell Carcinoma and B-Cell Hematological Malignancy. Blood. 120(21). 5086–5086. 2 indexed citations

19.

Varella, Leticia & Brian I. Rini. (2010). Emerging drugs for renal cell carcinoma. Expert Opinion on Emerging Drugs. 15(3). 343–353. 6 indexed citations

20.

Karam, José A., Brian I. Rini, Leticia Varella, et al.. (2010). Metastasectomy After Targeted Therapy in Patients With Advanced Renal Cell Carcinoma. The Journal of Urology. 185(2). 439–444. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact